HEADER ONCOPROTEIN 22-JUL-22 8DSO TITLE STRUCTURE OF CIAP1, BTK AND BCCOV COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: B; COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; COMPND 10 CHAIN: D; COMPND 11 SYNONYM: CELLULAR INHIBITOR OF APOPTOSIS 1,C-IAP1,IAP HOMOLOG B, COMPND 12 INHIBITOR OF APOPTOSIS PROTEIN 2,HIAP2,RING FINGER PROTEIN 48,RING- COMPND 13 TYPE E3 UBIQUITIN TRANSFERASE BIRC2,TNFR2-TRAF-SIGNALING COMPLEX COMPND 14 PROTEIN 2; COMPND 15 EC: 2.3.2.27; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: BIRC2, API1, MIHB, RNF48; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 LIGASE, PROTAC, TERNARY COMPLEX, BTK, ONCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SCHIEMER,M.F.CALABRESE REVDAT 3 01-MAY-24 8DSO 1 JRNL REVDAT 2 25-OCT-23 8DSO 1 REMARK REVDAT 1 08-MAR-23 8DSO 0 JRNL AUTH J.SCHIEMER,A.MAXWELL,R.HORST,S.LIU,D.P.UCCELLO,K.BORZILLERI, JRNL AUTH 2 N.RAJAMOHAN,M.F.BROWN,M.F.CALABRESE JRNL TITL A COVALENT BTK TERNARY COMPLEX COMPATIBLE WITH TARGETED JRNL TITL 2 PROTEIN DEGRADATION. JRNL REF NAT COMMUN V. 14 1189 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36864023 JRNL DOI 10.1038/S41467-023-36738-Z REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 110.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 59.3 REMARK 3 NUMBER OF REFLECTIONS : 17804 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.242 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 854 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 6.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3443 REMARK 3 BIN FREE R VALUE : 0.5295 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 12 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2683 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38270 REMARK 3 B22 (A**2) : -0.38270 REMARK 3 B33 (A**2) : 0.76530 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.410 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.446 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.319 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.456 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.322 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.880 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2925 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4046 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 959 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 525 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2844 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 353 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2242 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.27 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DSO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1000267299. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17804 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.334 REMARK 200 RESOLUTION RANGE LOW (A) : 110.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.73 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5P9J REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BTP PH 9, 4M POTASSIUM FORMATE, REMARK 280 AND 2% PEG MME 2K, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 383 REMARK 465 ALA B 384 REMARK 465 PRO B 385 REMARK 465 SER B 386 REMARK 465 THR B 387 REMARK 465 ALA B 388 REMARK 465 GLY B 389 REMARK 465 LEU B 390 REMARK 465 GLY B 391 REMARK 465 ARG B 490 REMARK 465 HIS B 491 REMARK 465 LEU B 547 REMARK 465 ASP B 548 REMARK 465 ASP B 549 REMARK 465 GLU B 550 REMARK 465 TYR B 551 REMARK 465 THR B 552 REMARK 465 SER B 553 REMARK 465 SER B 554 REMARK 465 GLY D 254 REMARK 465 SER D 255 REMARK 465 GLY D 256 REMARK 465 PRO D 257 REMARK 465 GLY D 258 REMARK 465 SER D 259 REMARK 465 SER D 260 REMARK 465 TYR D 352 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR B 392 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE B 397 CG1 CG2 CD1 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 GLU B 407 CG CD OE1 OE2 REMARK 470 THR B 410 OG1 CG2 REMARK 470 VAL B 415 CG1 CG2 REMARK 470 LYS B 417 CG CD CE NZ REMARK 470 ARG B 422 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 434 CG CD OE1 OE2 REMARK 470 GLU B 439 CG CD OE1 OE2 REMARK 470 GLU B 441 CG CD OE1 OE2 REMARK 470 ILE B 443 CG1 CG2 CD1 REMARK 470 GLU B 444 CG CD OE1 OE2 REMARK 470 GLU B 445 CG CD OE1 OE2 REMARK 470 LYS B 447 CG CD CE NZ REMARK 470 GLU B 455 CG CD OE1 OE2 REMARK 470 THR B 465 OG1 CG2 REMARK 470 LYS B 466 CG CD CE NZ REMARK 470 ARG B 468 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 470 CG1 CG2 CD1 REMARK 470 GLU B 488 CG CD OE1 OE2 REMARK 470 GLN B 494 CG CD OE1 NE2 REMARK 470 GLN B 496 CG CD OE1 NE2 REMARK 470 ARG B 544 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 546 CG1 CG2 REMARK 470 VAL B 555 CG1 CG2 REMARK 470 SER B 557 OG REMARK 470 LYS B 573 CG CD CE NZ REMARK 470 GLU B 599 CG CD OE1 OE2 REMARK 470 GLU B 608 CG CD OE1 OE2 REMARK 470 ILE B 610 CG1 CG2 CD1 REMARK 470 GLU B 636 CG CD OE1 OE2 REMARK 470 ASP B 639 CG OD1 OD2 REMARK 470 GLU B 640 CG CD OE1 OE2 REMARK 470 LYS B 645 CG CD CE NZ REMARK 470 ASP B 653 CG OD1 OD2 REMARK 470 GLU B 657 CG CD OE1 OE2 REMARK 470 GLU B 658 CG CD OE1 OE2 REMARK 470 SER B 659 OG REMARK 470 ILE D 261 CG1 CG2 CD1 REMARK 470 LEU D 264 CG CD1 CD2 REMARK 470 ARG D 332 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 334 CG CD OE1 OE2 REMARK 470 GLU D 343 CG CD OE1 OE2 REMARK 470 GLU D 347 CG CD OE1 OE2 REMARK 470 ARG D 351 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 424 -31.54 -130.62 REMARK 500 LYS B 433 124.44 -39.42 REMARK 500 GLU B 439 -40.68 74.65 REMARK 500 LYS B 466 -3.21 -59.51 REMARK 500 GLN B 516 17.02 56.38 REMARK 500 ARG B 520 -34.25 77.08 REMARK 500 ASP B 531 -8.98 -55.76 REMARK 500 PRO B 560 0.90 -63.04 REMARK 500 GLU B 608 41.45 -86.71 REMARK 500 HIS B 609 -45.72 -143.09 REMARK 500 TRP B 634 72.30 -108.89 REMARK 500 GLU B 658 -39.78 -133.96 REMARK 500 PHE D 276 20.51 -79.53 REMARK 500 ASN D 301 -114.05 42.82 REMARK 500 CYS D 308 -69.08 -90.44 REMARK 500 GLU D 334 2.52 -67.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS D 306 SG REMARK 620 2 CYS D 309 SG 100.4 REMARK 620 3 HIS D 326 NE2 121.2 115.6 REMARK 620 4 CYS D 333 SG 114.2 104.5 100.4 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8DSF RELATED DB: PDB DBREF 8DSO B 384 659 UNP Q06187 BTK_HUMAN 384 659 DBREF 8DSO D 260 352 UNP Q13490 BIRC2_HUMAN 260 352 SEQADV 8DSO SER B 383 UNP Q06187 EXPRESSION TAG SEQADV 8DSO GLY D 254 UNP Q13490 EXPRESSION TAG SEQADV 8DSO SER D 255 UNP Q13490 EXPRESSION TAG SEQADV 8DSO GLY D 256 UNP Q13490 EXPRESSION TAG SEQADV 8DSO PRO D 257 UNP Q13490 EXPRESSION TAG SEQADV 8DSO GLY D 258 UNP Q13490 EXPRESSION TAG SEQADV 8DSO SER D 259 UNP Q13490 EXPRESSION TAG SEQRES 1 B 277 SER ALA PRO SER THR ALA GLY LEU GLY TYR GLY SER TRP SEQRES 2 B 277 GLU ILE ASP PRO LYS ASP LEU THR PHE LEU LYS GLU LEU SEQRES 3 B 277 GLY THR GLY GLN PHE GLY VAL VAL LYS TYR GLY LYS TRP SEQRES 4 B 277 ARG GLY GLN TYR ASP VAL ALA ILE LYS MET ILE LYS GLU SEQRES 5 B 277 GLY SER MET SER GLU ASP GLU PHE ILE GLU GLU ALA LYS SEQRES 6 B 277 VAL MET MET ASN LEU SER HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 277 TYR GLY VAL CYS THR LYS GLN ARG PRO ILE PHE ILE ILE SEQRES 8 B 277 THR GLU TYR MET ALA ASN GLY CYS LEU LEU ASN TYR LEU SEQRES 9 B 277 ARG GLU MET ARG HIS ARG PHE GLN THR GLN GLN LEU LEU SEQRES 10 B 277 GLU MET CYS LYS ASP VAL CYS GLU ALA MET GLU TYR LEU SEQRES 11 B 277 GLU SER LYS GLN PHE LEU HIS ARG ASP LEU ALA ALA ARG SEQRES 12 B 277 ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL LYS VAL SER SEQRES 13 B 277 ASP PHE GLY LEU SER ARG TYR VAL LEU ASP ASP GLU TYR SEQRES 14 B 277 THR SER SER VAL GLY SER LYS PHE PRO VAL ARG TRP SER SEQRES 15 B 277 PRO PRO GLU VAL LEU MET TYR SER LYS PHE SER SER LYS SEQRES 16 B 277 SER ASP ILE TRP ALA PHE GLY VAL LEU MET TRP GLU ILE SEQRES 17 B 277 TYR SER LEU GLY LYS MET PRO TYR GLU ARG PHE THR ASN SEQRES 18 B 277 SER GLU THR ALA GLU HIS ILE ALA GLN GLY LEU ARG LEU SEQRES 19 B 277 TYR ARG PRO HIS LEU ALA SER GLU LYS VAL TYR THR ILE SEQRES 20 B 277 MET TYR SER CYS TRP HIS GLU LYS ALA ASP GLU ARG PRO SEQRES 21 B 277 THR PHE LYS ILE LEU LEU SER ASN ILE LEU ASP VAL MET SEQRES 22 B 277 ASP GLU GLU SER SEQRES 1 D 99 GLY SER GLY PRO GLY SER SER ILE SER ASN LEU SER MET SEQRES 2 D 99 GLN THR HIS ALA ALA ARG MET ARG THR PHE MET TYR TRP SEQRES 3 D 99 PRO SER SER VAL PRO VAL GLN PRO GLU GLN LEU ALA SER SEQRES 4 D 99 ALA GLY PHE TYR TYR VAL GLY ARG ASN ASP ASP VAL LYS SEQRES 5 D 99 CYS PHE CYS CYS ASP GLY GLY LEU ARG CYS TRP GLU SER SEQRES 6 D 99 GLY ASP ASP PRO TRP VAL GLU HIS ALA LYS TRP PHE PRO SEQRES 7 D 99 ARG CYS GLU PHE LEU ILE ARG MET LYS GLY GLN GLU PHE SEQRES 8 D 99 VAL ASP GLU ILE GLN GLY ARG TYR HET TOO B 701 161 HET ZN D 401 1 HETNAM TOO (4S)-4-[2-(2-{4-[(2E)-4-{(3R)-3-[4-AMINO-3-(4- HETNAM 2 TOO PHENOXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1- HETNAM 3 TOO YL]PIPERIDIN-1-YL}-4-OXOBUT-2-EN-1-YL]PIPERAZIN-1- HETNAM 4 TOO YL}ETHOXY)ACETAMIDO]-1-{(2S)-2-CYCLOHEXYL-2-[(N- HETNAM 5 TOO METHYL-L-ALANYL)AMINO]ACETYL}-N-[(1R)-1,2,3,4- HETNAM 6 TOO TETRAHYDRONAPHTHALEN-1-YL]-L-PROLINAMIDE BOUND FORM HETNAM ZN ZINC ION FORMUL 3 TOO C61 H81 N13 O7 FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *72(H2 O) HELIX 1 AA1 TYR B 392 GLU B 396 5 5 HELIX 2 AA2 ASP B 398 LYS B 400 5 3 HELIX 3 AA3 GLU B 439 ASN B 451 1 13 HELIX 4 AA4 CYS B 481 MET B 489 1 9 HELIX 5 AA5 GLN B 494 LYS B 515 1 22 HELIX 6 AA6 GLY B 541 TYR B 545 5 5 HELIX 7 AA7 LYS B 558 SER B 564 5 7 HELIX 8 AA8 PRO B 565 SER B 572 1 8 HELIX 9 AA9 SER B 575 SER B 592 1 18 HELIX 10 AB1 THR B 602 ALA B 611 1 10 HELIX 11 AB2 LYS B 625 CYS B 633 1 9 HELIX 12 AB3 LYS B 637 ARG B 641 5 5 HELIX 13 AB4 THR B 643 GLU B 657 1 15 HELIX 14 AB5 ASN D 263 GLN D 267 5 5 HELIX 15 AB6 THR D 268 PHE D 276 1 9 HELIX 16 AB7 GLN D 286 ALA D 293 1 8 HELIX 17 AB8 ASP D 321 PHE D 330 1 10 HELIX 18 AB9 PHE D 335 GLY D 341 1 7 HELIX 19 AC1 GLY D 341 GLY D 350 1 10 SHEET 1 AA1 5 LEU B 402 GLY B 411 0 SHEET 2 AA1 5 GLY B 414 TRP B 421 -1 O TYR B 418 N LYS B 406 SHEET 3 AA1 5 TYR B 425 ILE B 432 -1 O ILE B 429 N LYS B 417 SHEET 4 AA1 5 PHE B 471 GLU B 475 -1 O ILE B 472 N LYS B 430 SHEET 5 AA1 5 LEU B 460 CYS B 464 -1 N GLY B 462 O ILE B 473 SHEET 1 AA2 2 LEU B 528 VAL B 529 0 SHEET 2 AA2 2 VAL B 535 LYS B 536 -1 O LYS B 536 N LEU B 528 SHEET 1 AA3 3 PHE D 295 TYR D 297 0 SHEET 2 AA3 3 VAL D 304 CYS D 306 -1 O LYS D 305 N TYR D 296 SHEET 3 AA3 3 GLY D 312 LEU D 313 -1 O LEU D 313 N VAL D 304 LINK SG CYS B 481 C52 TOO B 701 1555 1555 1.78 LINK SG CYS D 306 ZN ZN D 401 1555 1555 2.27 LINK SG CYS D 309 ZN ZN D 401 1555 1555 2.54 LINK NE2 HIS D 326 ZN ZN D 401 1555 1555 2.02 LINK SG CYS D 333 ZN ZN D 401 1555 1555 2.24 CISPEP 1 ARG B 468 PRO B 469 0 5.79 CRYST1 104.360 104.360 110.290 90.00 90.00 120.00 P 3 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009582 0.005532 0.000000 0.00000 SCALE2 0.000000 0.011065 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009067 0.00000